News

Mar/25 - BioDiscovery Releases Nexus Copy Number Professional Version 3 for DNA Copy Number Analysis and Visualization
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Copy Number Professional Version 3, an efficient, scalable, and intuitive means for research scientists to transform their raw genomic data into biological insights.

Mar/06 - NCI has Acquired a Site-License for BioDiscovery’s Nexus Copy Number Software
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research announced today that the National Cancer Institute has obtained a site-license for Nexus Copy Number, a powerful tool for analysis and visualization of chromosomal aberrations from microarray data.

Feb/01 - BioDiscovery Releases ImaGene 8.0 for Expression and aCGH Microarray Analysis
BioDiscovery Inc., the leading developer of integrated software solutions for microarray based research announced today the release of ImaGene 8.0 for microarray image analysis. The new features include improved auto-gridding, faster processing for highly dense arrays, and support for multi-sample arrays.

Nov/13 - BioDiscovery Joins Illumina Connect Bioinformatics Program
BioDiscovery announced today that it joined Illumina Connect, a bioinformatics program offered by Illumina, Inc., for downstream analysis of microarray data.

Oct/16 - Biodiscovery Releases Nexus CGH Version 2 for DNA Copy Number Analysis and Visualization
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of NEXUS CGH version 2, the first commercial software tool that provides easy, fast and powerful platform independent and cross-platform analysis of multiple array-based DNA copy number data sets, simultaneously.

BioDiscovery Snapshot


Founded
July 1997

Mission
BioDiscovery develops and sells advanced software solutions that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology

Financial Status
Privately held

Customers
Over 800 in over 30 countries

Core Competency
Image Analysis, Pattern Recognition, Enterprise Data Management, Knowledge Management, Gene Expression Analysis, and Bioinformatics


Logistics